132 related articles for article (PubMed ID: 31831160)
1. Design and synthesis of novel parabanic acid derivatives as anticonvulsants.
Aboutabl ME; Hassan RM; El-Azzouny AA; Aboul-Enein MN; Abd-Allah WH
Bioorg Chem; 2020 Jan; 94():103473. PubMed ID: 31831160
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and docking studies of novel benzopyrone derivatives as anticonvulsants.
Abd-Allah WH; Osman EEA; Anwar MA; Attia HN; El Moghazy SM
Bioorg Chem; 2020 May; 98():103738. PubMed ID: 32179283
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of 5-substituted 1-H-tetrazoles as potent anticonvulsant agents.
Liao AM; Wang T; Cai B; Jin Y; Cheon S; Chun C; Wang Z
Arch Pharm Res; 2017 Apr; 40(4):435-443. PubMed ID: 28040846
[TBL] [Abstract][Full Text] [Related]
5. Design and Synthesis of 5-Substituted Benzo[d][1,3]dioxole Derivatives as Potent Anticonvulsant Agents.
Dong S; Wang T; Hu C; Chen X; Jin Y; Wang Z
Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28092111
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular modeling studies, and anticonvulsant evaluation of novel 1-((2-hydroxyethyl)(aryl)amino)-N-substituted cycloalkanecarboxamides and their acetate esters.
Aboul-Enein MN; El-Azzouny AA; Amin KM; Aboutabl ME; Abo-Elmagd MI
Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800269. PubMed ID: 30461033
[TBL] [Abstract][Full Text] [Related]
7. Exploring new cyclohexane carboxamides based GABA agonist: Design, synthesis, biological evaluation, in silico ADME and docking studies.
Hamada Abd-Allah W; Abd El-Mohsen Anwar M; Mohammed ER; Elbaset MA; El Moghazy SM
Bioorg Chem; 2023 Jul; 136():106561. PubMed ID: 37119786
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Anticonvulsant Activity of Substituted-1,3-diazaspiro[4.5]decan-4-ones.
Aboul-Enein MN; El-Azzouny AA; Saleh OA; Amin KM; Maklad YA; Hassan RM
Arch Pharm (Weinheim); 2015 Aug; 348(8):575-88. PubMed ID: 26032619
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants.
Malik S; Ahuja P; Sahu K; Khan SA
Eur J Med Chem; 2014 Sep; 84():42-50. PubMed ID: 25014748
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5-phenyl-hydantoins.
Byrtus H; Obniska J; Czopek A; Kamiński K
Arch Pharm (Weinheim); 2011 Apr; 344(4):231-41. PubMed ID: 21469172
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
[TBL] [Abstract][Full Text] [Related]
12. Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.
Ugale VG; Bari SB
Arch Pharm (Weinheim); 2016 Nov; 349(11):864-880. PubMed ID: 27680868
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones.
Kamiński K; Obniska J; Chlebek I; Wiklik B; Rzepka S
Bioorg Med Chem; 2013 Nov; 21(21):6821-30. PubMed ID: 23993970
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Pharmacological Evaluation of New 3,4-Dihydroisoquinolin Derivatives Containing Heterocycle as Potential Anticonvulsant Agents.
Zhang HJ; Shen QK; Jin CM; Quan ZS
Molecules; 2016 Nov; 21(12):. PubMed ID: 27916842
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2,6-dicarbethoxy-3,5-diaryltetrahydro-1,4-thiazine-1,1-dioxide derivatives as potent anticonvulsant agents.
Edayadulla N; Ramesh P
Eur J Med Chem; 2015 Dec; 106():44-9. PubMed ID: 26519928
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of anticonvulsant activities of benzoxazole derivatives containing the 1,2,4-triazolone moiety.
Song MX; Huang Y; Wang S; Wang ZT; Deng XQ
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1800313. PubMed ID: 31330092
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Potential Anticonvulsant Agents.
Liu DC; Zhang HJ; Jin CM; Quan ZS
Molecules; 2016 Feb; 21(3):164. PubMed ID: 26938519
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of newer 5,6-dihydropyrimidine-2(1H)-thiones as GABA-AT inhibitors for anticonvulsant potential.
Sahu M; Siddiqui N; Iqbal R; Sharma V; Wakode S
Bioorg Chem; 2017 Oct; 74():166-178. PubMed ID: 28806600
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of anticonvulsant activities of 7-phenyl-4,5,6,7-tetrahydrothieno[3,2-b ]pyridine derivatives.
Wang S; Liu H; Wang X; Lei K; Li G; Li X; Wei L; Quan Z
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900106. PubMed ID: 31364202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
